Galmed Pharmaceuticals Stock Price - GLMD

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.05 -1.04% 4.75 4.55 4.8796 4.75 4.80 20:00:00
Bid Price Ask Price Spread Spread % News
4.44 5.99 1.55 25.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
650 82,300 $ 4.71 $ 387,688 78,223 3.02 - 7.70
Last Trade Time Type Quantity Stock Price Currency
16:00:05 formt 100 $ 4.75 USD

Galmed Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 100.48M 21.15M 17.60M $ - $ - -0.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Galmed Pharmaceuticals News

Date Time Source News Article
5/21/202016:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)
5/18/202016:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)
5/15/202016:53Edgar (US Regulatory)Report of Foreign Issuer (6-k)
5/15/202016:47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/14/202007:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)
5/14/202007:00PR Newswire (US)Galmed Pharmaceuticals Provides Business Update and Reports..
5/07/202008:30PR Newswire (US)Galmed Pharmaceuticals to Report First Quarter 2020..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.436.204.555.27109,510-0.68-12.52%
1 Month4.346.203.935.2496,5160.419.45%
3 Months4.816.203.024.2991,634-0.06-1.25%
6 Months4.457.383.025.29108,5880.306.74%
1 Year6.367.703.025.2088,794-1.61-25.31%
3 Years5.0927.063.0211.14147,498-0.34-6.68%
5 Years10.41727.062.7810.29104,733-5.67-54.4%

Galmed Pharmaceuticals Description

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Your Recent History
Galmed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200601 02:06:33